Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials

Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials

BackgroundChronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. Tongxinluo capsules (TXL) are widely used in China for treating CCS.ObjectivesTo systematically evaluate the therapeutic effects and safety of adding TXL to Western...

Full description

Saved in:
Bibliographic Details
Main Authors: Shi-Bing Liang, Yi-Fei Wang, Zhen-Chao Niu, Yu-Fei Li, Hui-Min Zheng, Jia-Ming Huan, Jie Yuan, Nicola Robinson, Jian-Ping Liu, Yun-Lun Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
chronic coronary syndromes
cardiovascular disease
Chinese herbal medicine
meta-analysis
systematic review
tongxinluo
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1499585/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1499585/full

Similar Items